Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
Titel:
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
Auteur:
Ponte, Jose F. Ab, Olga Lanieri, Leanne Lee, Jenny Coccia, Jennifer Bartle, Laura M. Themeles, Marian Zhou, Yinghui Pinkas, Jan Ruiz-Soto, Rodrigo